Cleared Special

K993708 - BIOMAGNETIC TECHNOLOGIES MAGNES 3600 WHOLE HEAD MEG (FDA 510(k) Clearance)

Class II Neurology device cleared through the Special 510(k) pathway - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1999
Decision
30d
Days
Class 2
Risk

K993708 is an FDA 510(k) clearance for the BIOMAGNETIC TECHNOLOGIES MAGNES 3600 WHOLE HEAD MEG. Classified as Source Localization Software For Electroencephalograph Or Magnetoencephalograph (product code OLX), Class II - Special Controls.

Submitted by Biomagnetic Technologies, Inc. (San Diego, US). The FDA issued a Cleared decision on December 3, 1999 after a review of 30 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1400 - the FDA neurology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Biomagnetic Technologies, Inc. devices

Submission Details

510(k) Number K993708 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 03, 1999
Decision Date December 03, 1999
Days to Decision 30 days
Submission Type Special
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
118d faster than avg
Panel avg: 148d · This submission: 30d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code OLX Source Localization Software For Electroencephalograph Or Magnetoencephalograph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1400
Definition Correlation Of Electrical Activity Of The Brain Using Various Neuroimaging Modalities For Source-localization
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - OLX Source Localization Software For Electroencephalograph Or Magnetoencephalograph

All 23
Devices cleared under the same product code (OLX) and FDA review panel - the closest regulatory comparables to K993708.
PreOp v3
K252565 · Clouds of Care · Feb 2026
NeuroMatch
K250239 · LVIS Corporation · May 2025
Sourcerer
K241513 · Brain Electrophysiology Laboratory Company, LLC · Sep 2024
TRIUX™ neo (NM27000N )
K233985 · Megin OY · May 2024
RICOH MEG
K210199 · Ricoh Company, Ltd. · Jul 2021